Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Zentalis Pharmaceuticals, Inc. (ZNTL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G EVENTIDE ASSET MANAGEMENT, LLC reports a 11.1% stake in Zentalis Pharmaceuticals, Inc.
02/14/2023 SC 13G TYBOURNE CAPITAL MANAGEMENT LTD reports a 3.9% stake in Zentalis Pharmaceuticals, LLC
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2023 SC 13G STATE STREET CORP reports a 5.4% stake in INITIAL FILING ZENTALIS PHARMACEUTICALS INC
02/06/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2022 SC 13G PRICE T ROWE ASSOCIATES INC reports a 9.6% stake in Zentalis Pharmaceuticals, Inc.
02/14/2022 SC 13G TYBOURNE CAPITAL MANAGEMENT LTD reports a 5.8% stake in Zentalis Pharmaceuticals, LLC
02/01/2022 SC 13G Avidity Partners Management LP reports a 6.7% stake in Zentalis Pharmaceuticals, Inc.
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/02/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/10/2020 SC 13G FMR LLC reports a 12.3% stake in ZENTALIS PHARMACEUTICALS INC
05/29/2020 SC 13G TYBOURNE CAPITAL MANAGEMENT HK LTD reports a 7.4% stake in Zentalis Pharmaceuticals, LLC
04/09/2020 SC 13G CITADEL ADVISORS LLC reports a 5.9% stake in Zentalis Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy